论文部分内容阅读
1994年以来,我院心血管内科对8例确诊为心房内血栓的患者试行了经静脉应用尿激酶(UK)或重组织织型纤溶酶原激活物(rt-PA)溶栓治疗,以减少心源性血栓栓塞的发生率。本研究的目的在于观察静脉溶栓治疗心房内血栓(特别是巨大血栓)的疗效及其并发症。现将结果报告如下。资料和方法一般资料:8例患者中,男4例,女4例,年龄24～52岁,均由经食道超声心动图(TEE)检查,证实为心
Since 1994, 8 patients diagnosed with atrial thrombosis have undergone thrombolysis via intravenous urokinase (UK) or recombinant tissue-type plasminogen activator (rt-PA) in our department of cardiology. Reduce the incidence of cardiac thromboembolism. The purpose of this study was to observe the efficacy and complications of intravenous thrombolysis in the treatment of atrial thrombi, especially giant thrombi. The results reported below. Materials and Methods General Information: 8 patients, 4 males and 4 females, aged 24 to 52 years, by transesophageal echocardiography (TEE) examination, confirmed that the heart